Clinical Trial Update: Cordimax China Post Market Surveillance [Phase 3]

View source ↗

Summary

Cordimax is undergoing Phase 3 post-market surveillance in China for coronary artery stenosis. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Stenosis

Drugs mentioned

• Cordimax

Snippet

Sponsor: Shandong Branden Med.Device Co.,Ltd | Conditions: Coronary Artery Stenosis | Phase 3 | Status: UNKNOWN